In this new role, Dr. Bernstein will support the company’s efforts to bring Remimazolam to the U.S. market. Remimazolam is an ultra-short-acting anesthetic.
Dr. Bernstein also serves as the director of the Center for Liver Diseases at North Shore LIJ Health System and professor of medicine at Hofstra North Shore LIJ School of Medicine.
More articles on gastroenterology:
What qualities should young GI physicians look for in a mentor?
GI physician leader to know: Dr. Gary Lichtenstein of Penn Medicine
ASGE recognizes Exeter Hospital: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.